Meanwhile, in pancreatic adenocarcinoma, high SLC1A5 expression can reduce the infiltrating levels of CD8+ T cells, and is negatively correlated with the immune enrichment of CD8+ T cells, cytotoxic cells, NK cells and CD4+ T cells [29]. This evidence concerns the gene CD8A and pancreatic adenocarcinoma.